Investigational treatment options in microscopic colitis

Expert Opinion on Investigational Drugs

Volumn 17, Issue 12, 2008, Pages 1829-1837

  Madisch, Ahmed ^a   Morgner, Andrea ^a   Stolte, Manfred ^b   Miehlke, Stephan ^a  

^a DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

^b INSTITUTE OF PATHOLOGY   (Germany)

Author keywords

Budesonide; Collagenous colitis; Diarrhea; Inflammatory bowel disease; Lymphocytic colitis; Mesalazine; Microscopic colitis

Indexed keywords

5 ACETAMIDOSALICYLIC ACID; AZATHIOPRINE; BISMUTH SALICYLATE; BOSWELLIA SERRATA EXTRACT; BUDESONIDE; COLESTYRAMINE; CORTICOSTEROID; ERYTHROMYCIN; LOPERAMIDE; MESALAZINE; METHOTREXATE; METRONIDAZOLE; OCTREOTIDE; OLSALAZINE; PLACEBO; PREDNISOLONE; PROBIOTIC AGENT; SALAZOSULFAPYRIDINE; SULFALAZINE;

CHRONIC DIARRHEA; CHRONIC DISEASE; CLINICAL TRIAL; COLLAGENOUS COLITIS; COLON MUCOSA; CROHN DISEASE; DRUG EFFECT; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERANCE; HISTOLOGY; HUMAN; INFLAMMATORY INFILTRATE; LONG TERM CARE; LYMPHOCYTIC COLITIS; MICROSCOPIC COLITIS; QUALITY OF LIFE; REMISSION; REVIEW; TREATMENT RESPONSE; ULCERATIVE COLITIS; UNSPECIFIED SIDE EFFECT; ANIMAL; COLITIS; PATHOLOGY; RANDOMIZED CONTROLLED TRIAL;

ADRENAL CORTEX HORMONES; ANIMALS; COLITIS; HUMANS; PROBIOTICS; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 58149401865     PISSN: 13543784     EISSN: None     Source Type: Journal    
DOI: 10.1517/13543780802514500     Document Type: Review

References (79)

1. Read NW, Krejs GJ, Read MG, et al. Chronic diarrhea of unknown origin. Gastroenterol 1980;76:264-271 (Pubitemid 10128497)
2. Lazenby AJ, Yardley JH, Giardiello FM, et al. Lymphocytic (microscopic) colitis: a comparative histopathologic study with particular reference to collagenous colitis. Hum Pathol 1989;20:18-28 (Pubitemid 19041991)
3. Lindstrom CG. Collagenous colitis with watery diarrhea a new entity? Pathol Eur 1976;11:87-93
4. Bogomoletz WV. Collagenous, microscopic and lymphocytic colitis. An evolving concept. Virchows Arch 1994;6:573-579
5. Pardi DS. Microscopic colitis: an update. Inflamm Bowel Dis 2004;10:860-870 (Pubitemid 39545230)
6. Fine KD, Seidel RH DO. The prevalence, anatomic distrubution and diagnosis of colonic causes of chronic diarrhea. Gastrointest Endos 2000;51:318-326 (Pubitemid 30149223)
7. Shah RJ, Bleau B, Gianelle RA. Usefulness of colonoscopy with biopsy in the evaluation of patients with chronic diarrhea. Am J Gastroenterol 2001;96:1091-1095 (Pubitemid 32319141)
8. Fernandez-Banares F, Salas A, Forne M, et al. Incidence of collagenous and lymphocytic colitis: a 5-year population-based study. Am J Gastroenterol 1999;94:418-423 (Pubitemid 29084662)
9. Bohr J, Tysk C, Eriksson S, Jarnerot G. Collagenous colitis in Orebro, Sweden, an epidemiological study 1984-1993. Gut 1995;37:394-397
10. Raclot G, Queneau PE, Ottignon Y. Incidence of collagenous colitis. a retrospective study in the east of France. Gastroenterol 1994;106:A23
11. Agnarsdottir M, Gunnlaugsson O, Orvar KB, et al. Collagenous and lymphocytic colitis in Iceland. Dig Dis Sci 2002;47:1122-1128 (Pubitemid 34439192)
12. Pardi DS, Smyrk TC, Kammer P. The epidemiology of microscopic colitis: a population-based study in Olmsted County. Gut 2007;56:504-508 (Pubitemid 46580505)
13. Bohr J, Tysk C, Eriksson S, et al. Collagenous colitis: a retrospective study of clinical presentation and treatment in 163 patients. Gut 1996;39:846-851 (Pubitemid 27049088)
14. Madisch A, Miehlke S, Kusnik B, et al. Lymphocytic colitis: clinical presentation, treatment and outcome of 207 patients. Gut 2007;56:A128
15. Madisch A, Miehlke S, Bartosch F, et al. Collagenous colitis: clinical presentation, treatment and outcome of 287 patients. Gastroenterol 2008;134:A620
16. Madisch A, Bethke B, Stolte M, Miehlke S. Is there an association of microscopic colitis and irritable bowel syndrome? A subgroup analysis of placebo-controlled trials. World J. Gastroenterol 2005;11:6409 (Pubitemid 43136873)
17. Limsui D, Pardi DS, Camilleri M, et al. Symptomatic overlap between irritable bowel syndrome and microscopic colitis. Inflamm Bowel Dis 2007;13:175-181 (Pubitemid 46806226)
18. Miehlke S, Schneider-Brachert W, Madisch A, et al. High Prevalence of Yersinia IgG and IgA in patients with collagenous Colitis. Gastroenterol 2003;124:A144
19. Bohr J, Tysk C, Eriksson S, Janerot G. Collagenous colitis: epidemiology, associated diseases and medical therapy. Gut 1994;35:A2
20. Fausa O, Forester A, Hovig T. Collagenous colitis: a clinical, histological and ultrastructural study. Scand J Gastroenterol 1985;20:8-23 (Pubitemid 15142054)
21. Mäkinen M, Niemelä S, Lehtola J, Karttunen TJ. Collagenous colitis and Yersinia enterocolitica infection. Dig Dis Sci 1998;43:1341-1346 (Pubitemid 28272573)
22. Bohr J, Nordfelth R, Tysk C, Janerot G. Yersinia species in collagenous colitis: a serologic study. Scand J Gastroenterol 2002;37:711-714 (Pubitemid 34620935)
23. Miehlke S, Madisch A, Morgner A, et al. Lack of association between Yersinia serum antibodies and both collagenous colitis and lymphocytic colitis. Gut 2007;56:A120
24. Ridell RH, Tanaka M, Mazzoleni G. Non-steroidal anti-inflammatory drugs as a possible cause of collagenous colitis: a case-control study. Gut 1992;33:683-686
25. Fernández-Bañares F, Esteve M, Espinós JC, et al. Drug consumption and the risk of microscopic colitis. Am J Gastroenterol 2007;102:324-330 (Pubitemid 46160546)
26. Ung KA, Gillber GL, Kilander A, Abrahamsson H. Role of bile acids and bile acid binding agents in patients with collagenous colitis. Gut 2000;46:170-175 (Pubitemid 30305841)
27. Ung KA, Kilander A, Willen R, Abrahamsson H. Role of bile acids in lymphocytic colitis. Hepatogastroenterology 2002;49:432-437 (Pubitemid 34606568)
28. Sylwestrovicz T, Kelly JK, Hwang WS, et al. Collagenous colitis and microscopic colitis: the watery diarrhea-colitis syndrome. Am J Gastroenterol 1989;84:763-768 (Pubitemid 19184379)
29. Griga T, Tromm A, Schmiegel W, et al. Collagenous colitis: implications for the role of vascular endothelial growth factor in repair mechanisms. Eur J Gastroenterol Hepatol 2004;16:397-402 (Pubitemid 38453418)
30. Taha Y, Raab Y, Larsson A, et al. Vascular endothelial growth factor (VEGF) - a possible mediator of inflammation and mucosal permeability in patients with collagenous colitis. Dig Dis Sci 2004;49:109-130 (Pubitemid 38183754)
31. Günther U, Schuppan D, Bauer M, et al. Fibrogenesis and fibrolysis in collagenous colitis. Patterns of procollagen types I and IV, matrix-metalloproteinase-1 and-13, and TIMP-1 gene expression. Am J Pathol 1999;155:493-503 (Pubitemid 29370399)
32. Madisch A, Miehlke S, Schreiber S, et al. Matrix metalloproteinase-9 gene polymorphism is associated with collagenous colitis. Gut 2006;55:A113
33. Madisch A, Hellmig S, Schreiber S, et al. NOD2/CARD15 gene polymorphisms are not associated with collagenous colitis. Int J Colorectal Dis 2007;22:425-428 (Pubitemid 46336247)
34. Goff JS, Barnett JL, Pelke T, Appelman HD. Collagenous colitis: histopathology and clinical course. Am J Gastroenterol 1997;92:57-60 (Pubitemid 27027029)
35. Bhullar DS, Tymms KE, Hillman L, Jain S. Treatment of collagenous colitis with methotrexate. Aust NZ J Med 1996;26:114-121 (Pubitemid 26094510)
36. Farah D, Mills P, Lee F, et al. Collagenous colitis: Possible response to sulfasalazine and local steroid therapy. Gastroenterol 1985;88:792-797 (Pubitemid 15130671)
37. Alberti FJ, Howell S. Olsalazine in collagenous colitis. Br J Clin Pract 1994;48:158-159 (Pubitemid 24161897)
38. Fiedler LM, George J, Sachar DB, et al. Treatment responses in collagenous colitis. Am J Gastroenterol 2001;96:818-821 (Pubitemid 32240737)
39. Bonner GF, Petras RE, Cheong DM, et al. Short- and long-term follow-up of treatment for lymphocytic and collagenous colitis. Inflamm Bowel Dis 2000;6:85-91
40. Delarive J, Saraga E, Dorta G, Blum A. Budesonide in the treatment of collagenous colitis. Digestion 1998;59:364-366 (Pubitemid 28360693)
41. Tromm A, Griga T, Mollmann HW, et al. Budesonide for the treatment of collagenous colitis: first results of a pilot trial. Am J Gastroenterol 1999;94:1871-1875: (Pubitemid 29315902)
42. Lanyi B, Dries V, Dienes HP, Kruis W. Therapy of prednisone-refractory collagenous colitis with budesonide. Int J Colorectal Dis 1999;14:58-61 (Pubitemid 29295305)
43. Tromm A, Niewerth U, Khoury M, et al. The probiotic E. coli strain Nissle 1917 for the treatment of collagenous colitis: first results of an open-label trial. Z Gastroenterol 2004;42:365-369
44. Vennamaneni SR, Bonner GF. Use of azathioprine or 6-mercaptopurine for treatment of steroid-dependent lymphocytic and collagenous colitis. Am J Gastroenterol 2001;96:2798-2799 (Pubitemid 32889230)
45. Fisher NC, Tutt A, Sim E, et al. Collagenous colitis responsive to octreotide therapy. J Clin Gastroenterol 1996;23:300-301 (Pubitemid 26422098)
46. Järnerot G, Tysk C, Bohr J, Eriksson S. Collagenous colitis and fecal stream diversion. Gastroenterology 1995;109:449-455
47. Riaz AA, Pitt J, Stirling RW, et al. Restorative proctocolectomy for collagenous colitis. J R Soc Med 2000;93:261 (Pubitemid 30311458)
48. Varghese L, Galandiuk S, Tremaine WJ, Burgart LJ. Lymphocytic colitis treated with proctocolectomy and ileal J-pouch-anal anastomosis: report of a case. Dis Colon Rectum 2002;45:123-126 (Pubitemid 34072763)
49. Williams RA, Gelfand DV. Total proctocolectomy and ileal pouch anal anastomosis to successfully treat a patient with collagenous colitis. Am J Gastroenterol 2000;95:2147 (Pubitemid 30629344)
50. Munck LK, Kjeldsen J, Philipsen E, et al. Incomplete remission with short-term prednisolone treatment in collagenous colitis: a randomized study. Scand J Gastroenterol 2003;38:606-610 (Pubitemid 36724039)
51. Miehlke S, Heymer P, Bethke B, et al. Budesonide treatment for collagenous colitis - a randomized, double-blind, placebo-controlled, multicenter trial. Gastroenterol 2002;123:978-984
52. Bonderup OK, Hansen JB, Birket-Smith L, et al. Budesonide treatment of collagenous colitis: a randomised, double-blind, placebo-controlled trial with morphometric analysis. Gut 2003;52:248-251 (Pubitemid 36115067)
53. Baert F, Schmit A, D'haens G, et al. Budesonide in collagenous colitis: a double-blind placebo-controlled trial with histologic follow-up. Gastroenterol 2002;122:20-25
54. Miehlke S, Madisch A, Bethke B, Stolte M. Time to remission with budesonide in collagenous colitis. Aliment Pharmacol Ther 2005;21:1507-1508
55. Chande N, McDonald JW, MacDonald JK. Interventions for treating collagenous colitis. Cochrane Database Syst Rev 2008 CD003575
56. Miehlke S, Madisch A, Voss C, et al. Long-term follow-up and predictive factors for clinical relapse in patients with collagenous colitis after induction of remission with budesonide capsules. Aliment Pharmacol Ther 2005;22:1115-1119
57. Bonderup OK, Hansen JB, Teglbjaerg PS, et al. Long-term budesonide treatment of collagenous colitis - a randomized, double-blind, placebo-controlled trial. Gut 2008 [Epub ahead of print]
58. Miehlke S, Madisch A, Bethke B, et al. Budesonide for maintenance treatment of collagenous colitis - a randomized, double-blind, placebo-controlled trial. Gastroenterol 2008; In press
59. Gerhardt H, Seifert F, Buvari P, et al. Therapy of active Crohn disease with Boswellia serrata extract H 15. Z . Gastroenterol 2001;39:11-17 (Pubitemid 32125556)
60. Madisch A, Miehlke S, Eichele E, et al. Boswellia serrata extract for the treatment of collagenous colitis: a randomized, double-blind, placebo-controlled, multicenter trial. Int J Colorectal Dis 2007;22:1445-1451 (Pubitemid 47543333)
61. Fine K, Ogunji F, Lee E, et al. Randomized, double-blind, placebo-controlled trial of bismuth subsalicylate for microscopic colitis. Gastroenterol 1999;116:A880
62. Available from: www.clinicaltrials.gov
63. Wildt S, Munck LK, Vinter-Jensen L, et al. Probiotic treatment of collagenous colitis: a randomized, double-blind, placebo-controlled trial with Lactobacillus acidophilus and Bifidobacterium animalis subsp. Lactis. Inflamm Bowel Dis 2006;12:395-401 (Pubitemid 43756201)
64. Calabrese C, Fabbri A, Areni A, et al. Mesalazine with or without cholestyramine in the treatment of microscopic colitis: randomized controlled trial. J Gastroenterol Hepatol 2007;22:809-814 (Pubitemid 46911015)
65. Chande N, McDonald JW, Macdonald JK. Interventions for treating lymphocytic colitis. Cochrane Database Syst Rev 2008;CD006096
66. Olesen M, Eriksson S, Bohr J, et al. Lymphocytic colitis: a retrospective clinical study of 199 Swedish patients. Gut 2004;53:536-541 (Pubitemid 38372978)
67. Miehlke S, Madisch A, Bethke B, et al. Budesonide in lymphocytic colitis - a randomized, double-blind, placebo-controlled trial. Gut 2007;56:A156
68. Häuser W, Grandt D. Quality of life measurement in gastroenterology - concepts, instruments and problems. Z Gastroenterol 2001;39:475-481 (Pubitemid 32612170)
69. Guyatt GH, Mitchell A, Irvine EJ, et al. A new measure of health status for clinical trials in inflammatory bowel disease. Gastroenterol 1989;96:804-810 (Pubitemid 19057603)
70. Irvine EJ, Feagan B, Rochon J, et al. Quality of life: a valid and reliable measure of therapeutic efficacy in the treatment of inflammatory bowel disease. Canadian Crohn's Relapse Prevention Trial Study Group. Gastroenterol 1994;106:287-296 (Pubitemid 24041204)
71. Irvine EJ, Greenberg GR, Feagan BG, et al. Quality of life rapidly improves with budesonide therapy for active Crohn's disease. Inflamm Bowel Dis 2000;6:181-187
72. Eypasch E, Williams JI, Wood-Dauphinee S, et al. Gastrointestinal quality of life index: development, validation and application of a new instrument. Br J Surg 1995;82:216-222
73. Bullinger M, Kirchberger I, Ware J. Der deutsche SF-36 Health Survey. übersetzung und psychometrische Testung eines krankheitsübergreifenden Instruments zur Erfassung der gesundheitsbezogenen Lebensqualität. Z Gesundheitswissenschaften 1995;3:21-36:
74. Irvine EJ, Zhou Q, Thompson AK. The Short Inflammatory Bowel Disease Questionnaire: a quality of life instrument for community physicians managing inflammatory bowel disease. Am J Gastroenterol 1996;91:1571-1578 (Pubitemid 26269173)
75. Madisch A, Heymer P, Voss C, et al. Oral Budesonide therapy improves quality of life in patients with collagenous colitis - results of placebo-controlled, multicenter trial. Int J Colorectal Dis 2005;20:312-316
76. Sailer M, Bussen D, Debus ES, et al. Quality of life in patients with benign anorectal disorders. Br J Surg 1998;85:1716-1719 (Pubitemid 28548354)
77. Barrat C, Capelluto E, Catheline JM, Champault GG. Quality of life 2 years after laparoscopic total fundoplication: a prospective study. Surg Laparosc Endosc Percutan Tech 2001;11:347-350 (Pubitemid 34015227)
78. Miehlke S, Madisch A, Mrwa J, et al. Quality of life (SF-36) is severely reduced in patients with collagenous and lymphocytic colitis [Abstract]. Can J Gastroenterol 2005;19 (Suppl B)
79. Madisch A, Morgner A, Henker C, et al. The SIBDQ is more suitable than SF-36 to measure improvement of quality of life in patients with collagenous colitis treated with budesonide. Gut 2006;55:A127